Trending Articles

  1. Lonza expands HPAPI capacity in Visp to boost its position in payload-linker manufacturing Investment supports Lonza’s position in the ADC space by further developing its integrated ADC offering and expanding commercial-scale supply of highly potent payload-linker...
  2. Merck to acquire Bio-Techne for $11.3bn, expanding bioprocessing and cell therapy capabilities The deal will add proteomics, spatial biology and cell therapy manufacturing technologies to Merck's Process Solutions business, with $140m in annual synergies targeted by year...
  3. SCHOTT Pharma invests in sterile cartridge production in Hungary SCHOTT Pharma breaks ground for a new production facility for ready-to-use cartridges in Hungary
  4. T-CURX acquires Pantherna Therapeutics to fast-track non-viral in vivo CAR-T pipeline Combining transposon-based CAR-T with Pantherna's LNP and mRNA platforms, T-CURX aims to accelerate clinical trials by a year and become Europe's first biotech with both...
  5. Adragos signs agreement with Towa Pharmaceutical to supply off-patent medicines Adragos Pharma Kawagoe KK has announced the signing of an agreement with Towa Pharmaceutical Co., Ltd, to establish a strategic collaboration aimed at ensuring the stable...

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

You may also like

Finance The expansion enables Icosagen to support biotechnology and biopharmaceutical companies globally across discovery, developability assessment, CMC development and Phase I/II GMP...
Icosagen completes €45m expansion to bring discovery, development and GMP manufacturing under one roof

Icosagen completes €45m expansion to bring discovery, development and GMP manufacturing under one roof

Read more
Research & Development Adragos Pharma Kawagoe KK has announced the signing of an agreement with Towa Pharmaceutical Co., Ltd, to establish a strategic collaboration aimed at ensuring the stable...
Adragos signs agreement with Towa Pharmaceutical to supply off-patent medicines

Adragos signs agreement with Towa Pharmaceutical to supply off-patent medicines

Read more
Finance Investment supports Lonza’s position in the ADC space by further developing its integrated ADC offering and expanding commercial-scale supply of highly potent payload-linker...
Lonza expands HPAPI capacity in Visp to boost its position in payload-linker manufacturing

Lonza expands HPAPI capacity in Visp to boost its position in payload-linker manufacturing

Read more
Manufacturing SCHOTT Pharma breaks ground for a new production facility for ready-to-use cartridges in Hungary
SCHOTT Pharma invests in sterile cartridge production in Hungary

SCHOTT Pharma invests in sterile cartridge production in Hungary

Read more
Finance The deal will add proteomics, spatial biology and cell therapy manufacturing technologies to Merck's Process Solutions business, with $140m in annual synergies targeted by year...
Merck to acquire Bio-Techne for $11.3bn, expanding bioprocessing and cell therapy capabilities

Merck to acquire Bio-Techne for $11.3bn, expanding bioprocessing and cell therapy capabilities

Read more
Research & Development Located in one of Europe’s leading life sciences hubs, the Zurich facility serves as a key component of the company’s global bioanalytical network.
Celerion expands Zurich bioanalytical laboratory to meet growing market demand

Celerion expands Zurich bioanalytical laboratory to meet growing market demand

Read more
Finance French biopharma QC specialist Clean Cells has bought Stem Genomics, adding genomic stability testing for stem cell therapies and strengthening its US footprint in Durham,...
Clean Cells acquires Stem Genomics to expand cell therapy QC

Clean Cells acquires Stem Genomics to expand cell therapy QC

Read more
Finance The financing supports a European CTA filing with the EMA for arteriovenous fistula maturation failure in end-stage kidney disease, expanding APAC's clinical programme across...
Aplagon closes €4.8m round to advance first-in-class antithrombotic APAC into Phase II AVF trial

Aplagon closes €4.8m round to advance first-in-class antithrombotic APAC into Phase II AVF trial

Read more
Finance The ARK Venture Fund has previously invested in tech platforms such as OpenAI and Anthropic and is now backing the life sciences company to solve cell therapy's scaling problem
ARK Invest backs Cellares to mass manufacture cell therapies with $20m investment

ARK Invest backs Cellares to mass manufacture cell therapies with $20m investment

Read more
Manufacturing AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and...
AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn

AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn

Read more
Finance GSK has agreed to acquire clinical-stage oncology company Nuvalent for $10.6bn, securing two late-stage next-generation kinase inhibitors — zidesamtinib and neladalkib —...
GSK acquires Nuvalent for $10.6bn to accelerate NSCLC pipeline with FDA-reviewed ROS1 and ALK inhibitors

GSK acquires Nuvalent for $10.6bn to accelerate NSCLC pipeline with FDA-reviewed ROS1 and ALK inhibitors

Read more
Finance Heligan Group's latest report records just 53 deals, down from 72 in Q1 2025, with pharma and life sciences remaining most active despite tighter financing conditions and...
UK healthcare M&A drops 26% in Q1 2026 amid geopolitical tension and financing pressures

UK healthcare M&A drops 26% in Q1 2026 amid geopolitical tension and financing pressures

Read more
Finance From a $86.6m Series B for first-in-class ADCs to a $1.25bn haematology acquisition, this week's deals reflect sustained biopharma investment in next-generation therapeutic...
ADC funding, spatial biology investment and haematology M&A signal biopharma pipeline momentum

ADC funding, spatial biology investment and haematology M&A signal biopharma pipeline momentum

Read more
Finance SCHOTT Pharma has inaugurated new production lines for both standard and sterile ready-to-use (RTU) glass vials designed to store a wide range of drugs — from biologics and...
Strengthening US pharmaceutical supply: SCHOTT Pharma inaugurates expanded vial production in Lebanon, PA

Strengthening US pharmaceutical supply: SCHOTT Pharma inaugurates expanded vial production in Lebanon, PA

Read more
Manufacturing After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity to...
Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe

Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe

Read more
Finance Combining transposon-based CAR-T with Pantherna's LNP and mRNA platforms, T-CURX aims to accelerate clinical trials by a year and become Europe's first biotech with both...
T-CURX acquires Pantherna Therapeutics to fast-track non-viral in vivo CAR-T pipeline

T-CURX acquires Pantherna Therapeutics to fast-track non-viral in vivo CAR-T pipeline

Read more